ReportGem ReportGem EN

实时全球研报

U.S. First to Market

发布日期: 2026-07-01研究机构: JPMorgan报告页数: 17原文语言: English证据页码: 1

研报英文原文证据摘录

U.S. First to Market

North America Equity Research

U.S. First to Market 01 July 2026

Top Stories

U.S. Mid- and Small-Cap Banks 2Q26 Earnings Preview (Anthony Elian, CFA)

With Headwinds Including Deposit Cost Competition Still At Play for Regional Banks, We Remain

Cautious

Heading into 2Q26 earnings season for regional banks, we expect fundamental trends for the quarter to be highlighted by (1)

loan and deposit growth each in the mid-single digit annualized range, (2) NIMs to increase a couple bps q/q on average, and

(3) credit trends remaining stable overall. Although regional banks have significantly outperformed the broader markets over

the past month, with the KRX +8.2% vs.

Init | Allegiant Travel Company (James M Kirby) (ALGT, OW, PT $156.00)

Here Comes the Sun (Country), Opportune Time to Buy Leader of New-Look LCCs

We are initiating coverage of Allegiant Travel Company with an Overweight rating and a Dec 2027 price target of $156. The

demise of the Ultra-Low-Cost Carrier model has been widely reported given their paucity of premium, international, and loyalty,

which has driven a sustainable advantage for Legacy carriers. Spirit’s cessation of operations in early May (accelerated, though

not caused, in our view, by fuel), preceded by its second bankruptcy filing in a 12-month span, is the most notable proof point.

Mentions

Analyst Focus List (Ken Goldman)

U.S. Equity Thematic Research

PepsiCo (Andrea Teixeira, CFA) (PEP, OW, PT $170.00)

2Q26 Preview: Pullback Provides Opportunity on Delayed, Not Derailed, Recovery

NIKE, Inc. (Matthew R. Boss, CPA) (NKE, N, PT $47.00)

4Q Exit Rate Moderation = 1H27 Top-Line Cut; Mgmt Follow-Up Takes; Neutral

Medical Devices (Robbie Marcus, CFA)

本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。

打开研报阅读器